Stereotaxis STXS
NYSE STXS
$1.30 -0.02 (-1.52%)
As of: Sep 10, 2026 · 3:59 PM EDT

Stereotaxis (STXS) Total Non-Current Liabilities (2010 - 2026)

Stereotaxis' (STXS) quarterly Total Non-Current Liabilities came in at $29.3 million in Q1 2026, down 6.23% year-over-year from $31.3 million in Q1 2025, and up 1.8% quarter-over-quarter from $28.8 million in Q4 2025.

Analysis

Stereotaxis (STXS) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends

Stereotaxis (STXS) has reported Total Non-Current Liabilities for 17 consecutive years, with $29.3 million the latest figure, recorded in Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities fell 6.23% year-over-year to $29.3 million in Q1 2026; TTM through Mar 2026 was $29.3 million, a 6.23% decrease from a year earlier, with the FY2025 full-year figure at $28.8 million, down 1.23% from the prior year.
  • Total Non-Current Liabilities was $29.3 million for Q1 2026 at Stereotaxis, up from $28.8 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $31.3 million in Q1 2025 and troughed at $19.2 million in Q2 2024.
  • A 5-year average of $24.0 million and a median of $21.4 million in 2022 frame the typical range for Total Non-Current Liabilities.
  • Across the five-year window, Total Non-Current Liabilities fell 10.5% in 2023 and soared 61.37% in 2025, its largest moves.
  • Over 5 years, Total Non-Current Liabilities stood at $21.4 million in 2022, then declined by 6.94% to $19.9 million in 2023, then jumped by 46.22% to $29.2 million in 2024, then dropped by 1.23% to $28.8 million in 2025, then climbed by 1.8% to $29.3 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at $29.3 million (Q1 2026), $28.8 million (Q4 2025), and $27.0 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn -
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn 1.92 Bn
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn 40.46 Bn
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn 21.28 Bn
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn 17.56 Bn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn 2.57 Bn
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn 6.34 Bn
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn 3.68 Bn
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn 3.44 Bn
10 Stereotaxis 129.55 Mn 114.93 Mn 3.79 Mn 29.32 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 29.32 Mn
Dec 31, 2025 28.81 Mn
Sep 30, 2025 27.04 Mn
Jun 30, 2025 28.04 Mn
Mar 31, 2025 31.27 Mn
Dec 31, 2024 29.17 Mn
Sep 30, 2024 28.46 Mn
Jun 30, 2024 19.20 Mn
Mar 31, 2024 19.38 Mn
Dec 31, 2023 19.95 Mn
Sep 30, 2023 20.19 Mn
Jun 30, 2023 21.30 Mn
Mar 31, 2023 21.37 Mn
Dec 31, 2022 21.43 Mn
Sep 30, 2022 22.56 Mn
Jun 30, 2022 20.95 Mn
Mar 31, 2022 19.32 Mn
Dec 31, 2021 21.34 Mn
Sep 30, 2021 21.55 Mn
Jun 30, 2021 15.08 Mn